1. Global Tuberculosis Report;WHO,2022
2. Latent Mycobacterium tuberculosis infection;Getahun;N. Engl. J. Med.,2015
3. Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics,2017
4. New Drugs at FDA: CDER’s New Molecular Entities and New Therapeutic Biological Products,2023
5. Updates in the treatment of active and latent tuberculosis;Haas;Semin. Respir. Crit. Care Med.,2018